Alzinova AB (publ)

Stockholm Stock Exchange ALZ.ST

Alzinova AB (publ) Dividend Per Share for the year ending December 31, 2023: USD -0.00

Alzinova AB (publ) Dividend Per Share is USD -0.00 for the year ending December 31, 2023, a 0.00% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.

Alzinova AB (publ) Dividend Per Share for the year ending December 31, 2022 was USD -0.00, a 0.00% change year over year.
Alzinova AB (publ) Dividend Per Share for the year ending December 31, 2021 was USD -0.00, a 0.00% change year over year.
Alzinova AB (publ) Dividend Per Share for the year ending December 31, 2020 was USD -0.00, a 0.00% change year over year.
Alzinova AB (publ) Dividend Per Share for the year ending December 31, 2019 was USD -0.00, a 0.00% change year over year.

Key data

Date	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)

Stockholm Stock Exchange: ALZ.ST

Alzinova AB (publ)

CEO	Dr. Tord Labuda M.Sc., Ph.D.
IPO Date	Nov. 25, 2015
Location	Sweden
Headquarters	Pepparedsleden 1
Employees	5
Sector	Healthcare
Industries Biotechnology 3D Printing Pharmaceuticals Vaccines

Description

Alzinova AB (publ), a biopharma company, engages in the development of an active immunotherapy for the treatment of Alzheimer's disease in Sweden. Its lead candidate is ALZ-101, an oligomer-specific vaccine for the treatment of Alzheimer's disease; and ALZ-201, a monoclonal antibody that is used for the treatment of toxic Aß oligomers. The company was founded in 2011 and is based in Mölndal, Sweden.

Key trends

Past 5 years